Contested Proxy Solicitation
We represented NB Public Equity KS, a Danish health care fund, in the successful bid to replace the board of directors of QLT Inc. with a new slate of directors in June, 2012. QLT Inc. is a well-known Canadian biotech company which specializes in treatments for eye disorders. Its shares are publicly traded on NASDAQ and the Toronto Stock Exchange. Since the change of the board, we have advised QLT Inc. and the new board in respect of ongoing Canadian corporate and securities compliance.